We are thrilled to announce that the GenDx Companion Diagnostics team is heading to London for the 16th Annual CB & CDx Summit Europe. As the landscape of companion diagnostics continues to evolve, this summit provides a fantastic opportunity to connect with industry leaders, explore our comprehensive CDx services, and tackle the pressing challenges in drug-diagnostic co-development.
Event Details
-
Dates: March 30 – April 1, 2026
-
Location: London, UK
-
More Info: 16th Annual CB & CDx Summit Europe Website
Featured panel discussion
If you are attending, make sure to mark your calendar for an insightful panel discussion on the realities and complexities of partnerships in the diagnostic space: “Grey Zones & Growing Pains: The Realities of Pharma-Dx Collaboration.” Our Director of Program Management & Compliance, Erica Kremer-Groot, will be a co-panelist alongside Nicole Chaves Petronzi, Senior Director Global Regulatory Affairs Diagnostics at Eli Lilly & Co.
-
Date & Time: March 31, 2026 | 4:50 PM
-
Track: Track B: Clinical & CDx Development
-
Hosted by: Kirsten Van Garsse, Director Authorised Representative Services & Manager IVD, QbD Group
Upcoming GenDx CDx Webinar
Can’t make it to London, or looking to dive even deeper into the CDx topic?
On April 8, we are excited to offer the following webinar:
Navigating Grey Zones & Growing Pains: Developments in the Regulatory CDx Space
Follow the link above to register and secure your spot to learn more about the latest regulatory shifts and how to successfully navigate them.
Whether we see you in London or online at our webinar, we look forward to connecting with you. Follow the link below and find out more about our Companion Diagnostics services and about how we can support your next breakthrough!
